Terms ending in 2030
Advanced Cardiovascular Systems, Inc.
Every in-force patent on Advanced Cardiovascular Systems, Inc.'s record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,333,000 | Methods for Improving Stent Retention on a Balloon Catheter In force · High confidence | Abbott Cardiovascular Systems Inc. | In force | High confidence | |
| US 7,971,333 | Manufacturing Process for Polymeric Stents In force · High confidence | Ebara Technologies, Inc. | In force | High confidence | |
| US 8,021,678 | Implantable Medical Device with Polymer Coating in a Surface Area to Volume Ratio Providing Surface Erosion Characteristics In force · High confidence | Advanced Cardiovascular Systems, Inc. | In force | High confidence |
3 of 3 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Advanced Cardiovascular Systems, Inc..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.